DE1957706C3 - Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis - Google Patents

Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis

Info

Publication number
DE1957706C3
DE1957706C3 DE1957706A DE1957706A DE1957706C3 DE 1957706 C3 DE1957706 C3 DE 1957706C3 DE 1957706 A DE1957706 A DE 1957706A DE 1957706 A DE1957706 A DE 1957706A DE 1957706 C3 DE1957706 C3 DE 1957706C3
Authority
DE
Germany
Prior art keywords
propan
methylphenoxy
carbamoyl
ethylamino
xxx
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1957706A
Other languages
German (de)
English (en)
Other versions
DE1957706A1 (de
DE1957706B2 (de
Inventor
Joachim Linford Leicester Augstein
Allen Leslie Broadstairs Ham
Peter Rodway Canterbury Leeming
Michael Sandwich Snarey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB28492/69A external-priority patent/GB1245148A/en
Application filed by Pfizer Corp SRL filed Critical Pfizer Corp SRL
Publication of DE1957706A1 publication Critical patent/DE1957706A1/de
Publication of DE1957706B2 publication Critical patent/DE1957706B2/de
Application granted granted Critical
Publication of DE1957706C3 publication Critical patent/DE1957706C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1957706A 1968-11-18 1969-11-17 Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis Expired DE1957706C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB28492/69A GB1245148A (en) 1968-11-18 1968-11-18 Propanolamine derivatives
GB5453468 1968-11-18

Publications (3)

Publication Number Publication Date
DE1957706A1 DE1957706A1 (de) 1970-05-27
DE1957706B2 DE1957706B2 (de) 1977-11-03
DE1957706C3 true DE1957706C3 (de) 1978-06-29

Family

ID=26259405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1957706A Expired DE1957706C3 (de) 1968-11-18 1969-11-17 Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis

Country Status (9)

Country Link
US (1) US3723524A (https=)
JP (1) JPS501012B1 (https=)
BE (1) BE741762A (https=)
CA (1) CA957364A (https=)
CH (1) CH522588A (https=)
DE (1) DE1957706C3 (https=)
ES (1) ES373606A1 (https=)
FR (1) FR2023556B1 (https=)
SE (1) SE368197B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356322A (en) 1977-12-01 1982-10-26 Veb Arzneimittelwerk Dresden Phenoxyalkanolamine derivatives

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
LU66207A1 (https=) * 1972-09-29 1974-04-02
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
DE2309887C2 (de) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4041074A (en) * 1973-07-19 1977-08-09 Imperial Chemical Industries Limited 1-Hydroxyaryl-2-amidoalkylaminoethanol derivatives
GB1413911A (en) * 1973-08-18 1975-11-12 Pfizer Ltd Preparation of propanolamine derivatives
US4041075A (en) * 1973-12-12 1977-08-09 Imperial Chemical Industries Limited Phenoxy-alkanolamine derivatives
HU169464B (https=) * 1974-02-20 1976-11-28
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2285859A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Phenylsulfinyl-amidines et derives
US4165384A (en) * 1974-11-01 1979-08-21 Aktiebolaget Hassle Amide substituted phenoxy propanol amines
US4152446A (en) * 1974-11-16 1979-05-01 Boehringer Mannheim Gmbh Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases
US4151297A (en) * 1977-10-31 1979-04-24 Syntex (U.S.A.) Inc. Bicyclo [3.1.0] hexyl-substituted ethylamino carbonyl phenoxy cardiovascular agents
US4145443A (en) * 1977-10-31 1979-03-20 Syntex (U.S.A.) Inc. Bicyclo 3.1.0!hexylethylaminocarbonyl-substituted naphthyloxy cardiovascular agents
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
US4845127A (en) * 1978-07-03 1989-07-04 Eli Lilly And Company Phenethanolamines, compositions containing the same and method for effecting weight control
US4391826A (en) * 1978-07-03 1983-07-05 Eli Lilly And Company Phenethanolamines, compositions containing the same, and method for effecting weight control
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
EP0028105B1 (en) * 1979-10-25 1983-01-19 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
DE3162756D1 (en) * 1980-05-22 1984-04-26 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
US4410548A (en) * 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
US4554282A (en) * 1981-02-26 1985-11-19 Warner-Lambert Company Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method
DE3373466D1 (de) * 1982-06-10 1987-10-15 Beecham Wuelfing Gmbh & Co Kg Amine derivatives
US4599333A (en) * 1982-06-14 1986-07-08 Teikoku Hormone Mfg. Co., Ltd. Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament
US4556668A (en) * 1983-07-15 1985-12-03 American Hospital Supply Corporation Ethylenediamine derivatives of aryloxypropanolamine aryl esters having various medicinal properties
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
HU191313B (en) * 1984-01-12 1987-02-27 Eli Lilly And Co,Us Process for preparing compounds with inotropic activity
DE3428525A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von alkylendiamin-derivaten zur behandlung von durchblutungsstoerungen sowie arzneimittel, die diese verbindung enthalten
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPS6341451A (ja) * 1986-08-06 1988-02-22 Nippon Kayaku Co Ltd エ−テル誘導体およびそれを有効成分とする殺ダニ、殺虫組成物
EP0300290B1 (de) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phenoxypropanolamine
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB902617A (en) * 1959-04-22 1962-08-01 Pfizer Ltd Improvements in or relating to therapeutically-active alkylamines
GB1128052A (en) * 1965-06-08 1968-09-25 Ici Ltd Alkanolamine derivatives
NL301580A (https=) * 1962-12-11
GB1078852A (en) * 1964-09-30 1967-08-09 Ici Ltd Alkanolamine derivatives
GB1199632A (en) * 1967-09-07 1970-07-22 Ici Ltd Alkanolamine Derivatives
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356322A (en) 1977-12-01 1982-10-26 Veb Arzneimittelwerk Dresden Phenoxyalkanolamine derivatives

Also Published As

Publication number Publication date
FR2023556B1 (https=) 1974-05-24
DE1957706A1 (de) 1970-05-27
BE741762A (https=) 1970-05-19
ES373606A1 (es) 1972-06-01
CA957364A (en) 1974-11-05
FR2023556A1 (https=) 1970-08-21
CH522588A (fr) 1972-06-30
US3723524A (en) 1973-03-27
DE1957706B2 (de) 1977-11-03
JPS501012B1 (https=) 1975-01-14
SE368197B (https=) 1974-06-24

Similar Documents

Publication Publication Date Title
DE1957706C3 (de) Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DE2106209B2 (de) p-substituierte Phenoxypropanolamine, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
DE1643262C3 (de) i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2238504C3 (de) l-Phenoxy-S-alkylaminopropan^-ol -Derivate
EP0014951A2 (de) Heterocyclische Oxypropanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH637130A5 (de) Chinazolin-derivate, verfahren zu ihrer herstellung und verwendung dieser derivate in arzneimitteln.
DE2164636C3 (de) N-(Phenoxyalkyl)-a-methylphenäthylamine, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2434951C3 (de) In 3-stellung basisch substituierte diphenylhydantoine
DE2164637B2 (de) N-(phenoxyalkyl)-alpha-methylphenaethyl-amine bzw. -aminole, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DE2062055C3 (de) Propanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2023829C3 (de) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
EP0038936B1 (de) Neue 1-Aryloxy-3-alkylamino-2-propanole und Verfahren zu ihrer Herstellung
DE2163000C3 (de) (Piperidin-4-spiro)-5-oxazolidone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0442348B1 (de) Neue Imidazolverbindungen, Verfahren zu deren Herstellung, Arzneimittel auf Basis dieser Verbindungen sowie einige Zwischenprodukte
DE3207813C2 (https=)
DE2164638C3 (de) Kernsubstituierte Phenoxyäthylamine, Verfahren zu ihrer Herstellung und sie enthal tende Arzneimittel
EP0035733B1 (de) Neue 1-(Acylamino-aryloxy-)2-hydroxy-3-alkinyl-aminopropane und Verfahren zu ihrer Herstellung
DD275241A5 (de) Verfahren zur herstellung von neuen 1-aryloxy-3-amimo-2-propanolen
DE1643459C3 (de) 1 -(2-Methoxyphenoxy) -3-tert-butylamino-2-propanol und dessen Salze, Verfahren zu deren Herstellung und Arzneimittel
AT295526B (de) Verfahren zur Herstellung von neuen 1,2,5-Thiadiazolderivaten und ihren Salzen
DE1768653C3 (de) Sulfamylbenzoesäurederivate und diese enthaltende Arzneimittel
DE4036782A1 (de) Substituierte anilide
DE1518444C (de) erythro alpha Phenyl beta amino propanole, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arz neimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee